Jenny Yip

Jenny Yip

Director/Board Member at
ChromaCode, Inc.
Health Technology
Finance
Technology Services

Profile

Jenny Yip is currently the Director at Antiva Biosciences, Inc., Resurge International, ChromaCode, Inc., and Excision BioTherapeutics, Inc. She is also an Investment Advisor at RH Capital LLC.
Previously, she served as an Independent Director at Evofem Biosciences, Inc., Director at 54Gene, Inc., Vice President at The Goldman Sachs Group, Inc., Board Observer at Kymab Ltd. and Acrobatiq, Inc., Partner at Bill & Melinda Gates Foundation, and Managing Partner at Adjuvant Capital LP.
Ms. Yip obtained her undergraduate degree from Harvard University in 2003.

Jenny Yip active positions

CompaniesPositionStart
Director/Board Member 01/05/2020
Director/Board Member 01/11/2021
Director/Board Member 01/07/2022
Corporate Officer/Principal 01/02/2021
Consultant / Advisor -

Former positions of Jenny Yip

CompaniesPositionEnd
Private Equity Investor 01/07/2024
Director/Board Member 01/09/2023
EVOFEM BIOSCIENCES, INC. Director/Board Member 10/02/2023
Private Equity Investor 28/02/2019
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Jenny Yip's experience

Training of Jenny Yip

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Finance

Health Technology

Consumer Services

Health Technology

Health Services

Technology Services

Health Technology

Technology Services

Health Technology

Finance

Finance

Commercial Services

Health Technology